Company profile
Kiniksa Pharmaceuticals company profile
Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with a significant unmet medical need. It has a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune conditions. It has three clinical-stage product candidates, one of which is anticipated to commence a Phase 3 clinical trial in 2018. They follow a disciplined and methodical approach to selectively identify and acquire product candidates with strong biologic rationales or validated mechanisms of action. The company's portfolio of product candidates offers multiple development opportunities...... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.kiniksa.com/
- Contact email
- [email protected]
- Phone number
- (781) 431-9100
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00251-00500 employees
- Revenue range
- $100K+
- Founded
- 2015-01-01
Headquarters
- Headquarters
- Klouékanmè, Kouffo, Benin
- Postal code
- HM 11
- Country code
- BJ
- Continent
- Africa